DK0626943T3 - Bistriazener som kemoterapimidler - Google Patents
Bistriazener som kemoterapimidlerInfo
- Publication number
- DK0626943T3 DK0626943T3 DK92923053T DK92923053T DK0626943T3 DK 0626943 T3 DK0626943 T3 DK 0626943T3 DK 92923053 T DK92923053 T DK 92923053T DK 92923053 T DK92923053 T DK 92923053T DK 0626943 T3 DK0626943 T3 DK 0626943T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- bistriazene
- cancer
- bistriazenes
- chemotherapy agents
- Prior art date
Links
- 239000012829 chemotherapy agent Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 230000001093 anti-cancer Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003431 cross linking reagent Substances 0.000 abstract 1
- 229920002521 macromolecule Polymers 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C07D213/77—Hydrazine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/22—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond containing chains of three or more nitrogen atoms with one or more nitrogen-to-nitrogen double bonds
- C07C245/24—Chains of only three nitrogen atoms, e.g. diazoamines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78600191A | 1991-10-31 | 1991-10-31 | |
| PCT/US1992/009127 WO1993009089A1 (en) | 1991-10-31 | 1992-10-30 | Bistriazenes as chemotherapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0626943T3 true DK0626943T3 (da) | 2000-04-17 |
Family
ID=25137306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92923053T DK0626943T3 (da) | 1991-10-31 | 1992-10-30 | Bistriazener som kemoterapimidler |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0626943B1 (da) |
| JP (1) | JP3193379B2 (da) |
| AT (1) | ATE189207T1 (da) |
| AU (1) | AU665036B2 (da) |
| CA (1) | CA2122346C (da) |
| DE (1) | DE69230622T2 (da) |
| DK (1) | DK0626943T3 (da) |
| ES (1) | ES2141114T3 (da) |
| GR (1) | GR3032953T3 (da) |
| WO (1) | WO1993009089A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE513149C2 (sv) * | 1997-12-05 | 2000-07-17 | Katarina Edwards | Läkemedelsdistributionssystem med tvåstegsmålsökning, till specifika celler eller vävnad och till dess cellkärna |
| WO2020121304A1 (en) * | 2018-12-10 | 2020-06-18 | Ariel Scientific Innovations Ltd. | Therapeutic conjugates |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE514033A (fr) * | 1951-09-21 | 1954-05-14 | Cfmc | Procede d'obtention de colorants azoiques insolubles sur fibres. |
| US3947247A (en) * | 1973-10-31 | 1976-03-30 | Central Michigan University Board Of Trustees | Stabilizer composition for dyestuffs |
| DE3426644A1 (de) | 1984-07-19 | 1986-02-06 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, 6900 Heidelberg | N,n-bis((1-aryl-3-methyltriazen-3-yl) methyl)ether |
| EP0531419B1 (en) * | 1990-05-24 | 1999-07-28 | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, U.S. DEPARTMENT OF COMMERCE | Bistriazenes as chemotherapeutic agents |
-
1992
- 1992-10-30 WO PCT/US1992/009127 patent/WO1993009089A1/en not_active Ceased
- 1992-10-30 DE DE69230622T patent/DE69230622T2/de not_active Expired - Fee Related
- 1992-10-30 ES ES92923053T patent/ES2141114T3/es not_active Expired - Lifetime
- 1992-10-30 AT AT92923053T patent/ATE189207T1/de not_active IP Right Cessation
- 1992-10-30 CA CA002122346A patent/CA2122346C/en not_active Expired - Fee Related
- 1992-10-30 JP JP50851093A patent/JP3193379B2/ja not_active Expired - Fee Related
- 1992-10-30 DK DK92923053T patent/DK0626943T3/da active
- 1992-10-30 AU AU29103/92A patent/AU665036B2/en not_active Ceased
- 1992-10-30 EP EP92923053A patent/EP0626943B1/en not_active Expired - Lifetime
-
2000
- 2000-03-10 GR GR20000400649T patent/GR3032953T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2910392A (en) | 1993-06-07 |
| DE69230622D1 (de) | 2000-03-02 |
| ES2141114T3 (es) | 2000-03-16 |
| WO1993009089A1 (en) | 1993-05-13 |
| JPH07507042A (ja) | 1995-08-03 |
| AU665036B2 (en) | 1995-12-14 |
| DE69230622T2 (de) | 2000-07-20 |
| CA2122346C (en) | 2005-09-27 |
| CA2122346A1 (en) | 1993-05-13 |
| EP0626943A1 (en) | 1994-12-07 |
| EP0626943B1 (en) | 2000-01-26 |
| GR3032953T3 (en) | 2000-07-31 |
| JP3193379B2 (ja) | 2001-07-30 |
| ATE189207T1 (de) | 2000-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9303993A (pt) | Composto, processo para preparar o mesmo e composição farmacêutica | |
| MX9202166A (es) | Derivados de amidino fenil alanina, procedimiento para su preparacion su empleo y agentes que los con tienen en calidad de anticoagulantes. | |
| FI972580A0 (fi) | Valmisteita ja menetelmiä ihoärsytyksen vähentämiseksi | |
| YU13396A (sh) | N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima | |
| DK0531419T3 (da) | Bistriazener som kemoterapeutiske midler | |
| ES2133324T3 (es) | Compuestos de dibenzoxazepina sustituidos, composiciones farmaceuticas y metodos de uso. | |
| ATE102604T1 (de) | Diarylverbindungen als antiatherosklerotische mittel. | |
| DK0934065T3 (da) | Hidtil ukendte cruptophycinderivater som antieoplastiske midler | |
| DE59203006D1 (de) | Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel. | |
| ATE25241T1 (de) | Thioether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel. | |
| FI803264L (fi) | 2-hydroxialkyl-3,4,5-trihydroxipiperidiner foerfarande foer framstaellning av dem och anvaendning av dem som laekemedel | |
| ES2116612T3 (es) | Nuevas bis-naftalimidas para el tratamiento del cancer. | |
| DK0626943T3 (da) | Bistriazener som kemoterapimidler | |
| DK0521057T3 (da) | Farmaceutiske midler indeholdende ipriflavon, fremgangsmåde til fremstilling deraf, og relativ terapeutisk anvendelse | |
| DK0577745T3 (da) | Bis-naphtalimider indeholdende amid- og thioamid-forbindelsesstykker som anticancermidler. | |
| ITMI920084A1 (it) | Alchil derivati del trazodone | |
| DE60024628D1 (de) | Pharmazeutische und kosmetische zubereitungen enthaltend urocaninsäurederivate als antioxidationsmittel oder radikalenabfangermittel | |
| ATE233745T1 (de) | Arzneistoffe | |
| ES2145926T3 (es) | Derivados metalocenicos de diariletileno, metodos de preparacion y composiciones farmaceuticas que contienen estos derivados. | |
| BR0211762A (pt) | Certos policetìdeos substituìdos, composições farmacêuticas contendo os mesmos e seu uso no tratamento de tumores | |
| KR890017363A (ko) | 스트로빌루린 유도체, 이들의 제법 및 용도 | |
| KR950702942A (ko) | 암의 간전이 억제용 의약 조성물 및 간암 치료용 의약 조성물(pharmaceutical compositions for preventing liver metastasis of cancer and pharmaceutical composition for the treatment of liver cancer) | |
| BR9806923A (pt) | Composto de terbenzimidazol, uso do mesmo, composi;cão farmacêutica, e, processo teapêutico. | |
| RU94033096A (ru) | Соединение, способ лечения и фармацевтическая композиция |